RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA
Clinical trials for RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Nanoparticle therapy targets hard-to-treat bladder cancer in early trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called PPM for people with non-muscle invasive bladder cancer that has come back or not responded to standard care. PPM uses tiny particles coated with a targeting molecule to deliver a chemotherapy drug directly to cancer cells in the…
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 26, 2026 08:44 UTC
-
Broccoli vs. bladder cancer: new study tests veggie power
Disease control Recruiting nowThis study tests a healthy eating program that encourages people with early-stage bladder cancer to eat more cruciferous vegetables like broccoli, kale, and cabbage. These veggies contain natural compounds that may help keep cancer from returning or getting worse. The program inv…
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 08:40 UTC
-
New combo therapy aims to beat back bladder cancer recurrence
Disease control Recruiting nowThis phase 3 trial tests whether adding the chemotherapy drug gemcitabine to standard BCG immunotherapy can better prevent bladder cancer from coming back. About 330 people with recurrent high-grade non-muscle invasive bladder cancer will receive either BCG alone or BCG plus gemc…
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 11, 2026 20:41 UTC